Where to next for personal genomics?
Category: commercial genetic testing
The last week has seen the beginning of a likely massive regulatory crackdown on the personal genomics industry, with investigations into the field launched by the FDA and the US Congress. It seems likely that the result will be major regulatory burdens placed on the industry - an outcome that would do lasting damage to innovation in the nascent field of personalised medicine.
Posted by Daniel MacArthur at 8:35 PM • 67 Comments •
